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Focal segmental glomerulosclerosis (FSGS) is an important cause of proteinuria and nephrotic syndrome in humans. The
pathogenesis of FSGS may be associated with glomerular visceral epithelial cell (GEC; podocyte) injury, leading to apoptosis,
detachment, and “podocytopenia”, followed by glomerulosclerosis. Mutations in α-actinin-4 are associated with FSGS in humans.
In cultured GECs, α-actinin-4 mediates adhesion and cytoskeletal dynamics. FSGS-associated α-actinin-4 mutants show increased
binding to actin ﬁlaments, compared with the wild-type protein. Expression of an α-actinin-4 mutant in mouse podocytes
in vivo resulted in proteinuric FSGS. GECs that express mutant α-actinin-4 show defective spreading and motility, and such
abnormalities could alter the mechanical properties of the podocyte, contribute to cytoskeletal disruption, and lead to injury.
The potential for mutant α-actinin-4 to injure podocytes is also suggested by the characteristics of this mutant protein to form
microaggregates, undergo ubiquitination, impair the ubiquitin-proteasome system, enhance endoplasmic reticulum stress, and
exacerbate apoptosis.
1.Introduction
Glomerular visceral epithelial cells (GECs; podocytes) play
a key role in the maintenance of glomerular permselectivity
[1–4]. Under normal conditions, podocytes are in contact
with extracellular matrix, and there appears to be little
turnover of podocytes, as these cells are highly diﬀer-
entiated (“terminally diﬀerentiated”). GECs form a tight
network of interdigitating foot processes, which are bridged
by ﬁltration-slit diaphragms, and permselectivity of the
glomerular capillary wall is dependent on the maintenance
of appropriate structure of podocytes and of their foot
processes. The complex cellular architecture of the podocyte
is maintained by an organization of actin ﬁlaments in
the cytoplasm. Proteins including nephrin, neph1, FAT,
podocin, CD2AP and ZO-1 are found within or near the
slit diaphragm, and nephrin, neph family proteins, and
cadherins form complexes with scaﬀolding proteins, CD2AP
and ZO-1 [2, 4]. These connect the slit-diaphragm protein
complex with actin ﬁlaments, which are joined by α-actinin-
4 proteins.
Acquired GEC injury is frequently associated with eﬀace-
ment of the foot processes, disruption of the ﬁltration-
slit diaphragms, and proteinuria [1, 2]. Moreover, heritable
mutations in several GEC structural proteins alter podocyte
ultrastructure and cause heritable proteinuria, implying that
impairment of the slit diaphragm or cytoskeletal structure
underlies proteinuria [4, 5]. Focal segmental glomeruloscle-
rosis (FSGS) is an important cause of proteinuria and
nephroticsyndromeinhumans.Inrecentyears,evidencehas
accumulated to support the view that the early pathogenesis
of FSGS is associated with GEC injury, leading to apop-
tosis, detachment of GECs from extracellular matrix, and
“podocytopenia”, which is followed by glomerulosclerosis
[1–3, 6–8]. Acquired GEC injury may be triggered by2 Journal of Signal Transduction
immunological factors (e.g., T cell or other factors aﬀecting
permeability), oxidants, human immunodeﬁciency virus,
toxins, and other substances. In addition, FSGS may be
associated with heritable mutations in several distinct pro-
teins that play key roles in maintaining GEC ultrastructure,
including podocin, α-actinin-4, transient receptor potential
cation channel, subfamily C, member 6 (TRPC6), inverted
formin 2 and others [5]. In this paper, we focus on
mutations in α-actinin-4, which are associated with an
autosomal dominant late-onset FSGS in humans [9]. We
discuss the structure and function of α-actinin-4, and we
review mechanisms by which mutations in α-actinin-4 may
lead to podocyte injury and FSGS.
2. Role of α-Actinin-4inCellBiology
2.1. Structure of α-Actinin-4. Among the various cytoskeletal
proteins, α-actinin-4 plays an important role in podocyte
biology. There are four α-actinin genes (ACTN1-4) that
encode highly homologous proteins (α-actinin-1, 2, 3 and
4), which form ∼100kDa head-to-tail homodimers [10].
α-actinins-2 and -3 are Ca2+-insensitive muscle α-actinins
expressed in Z-discs of striated muscle cells [11], while α-
actinins-1 and -4 are widely distributed, nonmuscle isoforms
[12]. All family members are actin crosslinking proteins
that share a number of structural features and regulatory
regions. These include a central rod with four spectrin-like
repeats, two N-terminal calponin-homology domains (CH1
and CH2), which contain three actin-binding sites (ABS1-
3), a C-terminal calmodulin-like domain, containing two
putative EF hands, and a phosphoinositide-binding plex-
trin homology domain. The spectrin-like repeats facilitate
homodimerization and may confer a degree of ﬂexibility to
theα-actininmolecule,allowingittoresistmechanicalstrain
[13]. For its interaction with actin ﬁlaments, the CH1 and
CH2domainsadoptaclosedconformation,whereABS2and
3 are exposed, while ABS1 remains buried and inaccessible
to F-actin [14]. This association with actin is highly dynamic
and can be controlled by the regulatory regions along the α-
actinin sequence.
2.2. Regulation and Function of α-Actinin-4. All α-actinin
isoforms contain two putative EF-hand motifs at the C-
terminus of each monomer, but only isoforms 1 and 4
demonstrate sensitivity to Ca2+ [15, 16]. For these non-
muscle isoforms, binding of Ca2+ is believed to reduce the
aﬃnity of α-actinin for actin, providing a mechanism for
α-actinin-dependent cytoskeletal remodeling. Additionally,
extensive biochemical studies on the eﬀect of phosphoinosi-
tide binding to α-actinin-1 have been performed. Binding
of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), and
to a lesser extent phosphatidylinositol (4,5)-bisphosphate
(PIP2), decreases the association between α-actinin-1 and F-
actin,suggestingthatphosphoinositides mediatecytoskeletal
remodeling [17, 18]. For α-actinin-4, the phosphoinositide-
binding site is within the CH2 domain. In contrast to
ﬁndings for α-actinin-1, our studies showed that phospho-
inositides increase the interaction of α-actinin-4 with F-actin
[19]. Phosphorylation of α-actinin-1 has been reported in
activatedplatelets[20].Tyrosinephosphorylationatposition
12 was found to be dependent on focal adhesion kinase
(FAK), supporting a role for α-actinin in cell adhesion.
Phosphorylation of α-actinin-1 reduced its association with
F-actin in vitro, suggesting that α-actinin mediates FAK-
dependent cytoskeletal remodeling [21]. The amino acid
sequenceofα-actinin-4revealsananalogoustyrosineresidue
at position 32, suggesting that phosphorylation may also
regulate the binding of α-actinin-4 to F-actin. However,
we were unable to demonstrate FAK-dependent tyrosine
phosphorylation of α-actinin-4 (unpublished observations).
These ﬁndings suggest that regulation of α-actinin-1 and 4
are not identical.
Nonmuscle α-actinins are often regarded as simple actin
ﬁlament crosslinking proteins. Expression of these isoforms
at the cytoplasmic face of several types of cellular interaction
sites, including focal adhesions, adherens junctions, and
hemidesmosomes suggests a degree of versatility. The ﬁrst
α-actinin binding partners identiﬁed were the β subunits
of integrins and intercellular adhesion molecule-1 [12].
Interactions between α-actinin and adhesion receptors may
provide structural stability for the adhesion sites. Since
α-actinins also bind to various regulatory molecules, α-
actinin may also serve as a scaﬀolding protein to integrate
signaling molecules at various adhesion sites. α-actinin-1
may link membrane proteins such as talin, vinculin, and β-
integrins with the cortical actin cytoskeleton [10, 22–25].
Similarly, the tight junction protein, MAGI-1, interacts with
the C-terminus of α-actinin-4, providing a physical link
from the cell periphery to the cytoskeleton [26]. The list
of interacting proteins is likely to grow and will provide a
better understanding of the diverse functions of α-actinins in
nonmuscle tissues. However, the best deﬁned function of α-
actinin-4 is to crosslink/bundle actin ﬁlaments, and it may
enhance cell motility and elicit tumor-suppressor activity
[10].
Intriguingly, α-actinin-4 is reported to shuttle between
the cytoplasm and the nucleus. Cytoplasmic localization
was associated with an inﬁltrative phenotype and correlated
signiﬁcantly with a poorer prognosis in cases of breast cancer
[10]. In this context, the relevance of nuclear α-actinin-
4 remains unknown, although it has been suggested that
nuclear translocation may attenuate metastatic potential.
The nuclear localization of α-actinin-4 suggests a role for
α-actinin-4 in gene expression. α-actinins-1 and -4 were
identiﬁed as histone deacetylase 7 (HDAC7)-interacting
proteins, and the interaction domain was mapped to the C-
terminus of α-actinin 4 [27]. HDAC7 can participate in mul-
tiple cellular processes, including the regulation of myocyte
enhancer factor-2- (MEF2-) mediated transcription. A point
mutationinHDAC7disrupteditsassociationwithα-actinin-
4 and MEF2, implying that α-actinin-4 and MEF2 binding
sites overlap. Ectopic expression of α-actinin-4 disrupted the
HDAC7-MEF2A association, and enhanced MEF2-mediated
transcription.Overexpressionofα-actinin-4alsopotentiated
estrogen receptor α-mediated transcription by counteracting
a negative regulatory eﬀect of HDAC7, while knockdown
of α-actinin-4 decreased expression of estrogen receptor αJournal of Signal Transduction 3
target genes and aﬀected proliferation of cultured breast can-
cer cells [28]. Another study demonstrated that α-actinin-
4 colocalized along actin stress ﬁbers and in membrane
lamellae with nuclear factor-κB( N F - κB) [29]. Incubation of
cellswithepidermalgrowthfactorortumornecrosisfactor-α
induced translocation of α-actinin-4 and the p65 subunit of
NF-κB into the nucleus. Moreover, α-actinin-4 and the p65
underwent association. As NF-κB regulates transcription of
a large number of genes in response to diverse stimuli, the
study further supports a regulatory role for α-actinin-4 in
transcription.
3. α-Actinin-4inPodocyteBiology
3.1. α-Actinin-4 in the Normal Podocyte. Human GECs
express only α-actinin-4 (although mouse GECs also express
α-actinin-1) [10, 30]. Immunoelectron microscopy studies
showed that α-actinin localizes to contractile microﬁlaments
within podocyte foot processes [31, 32]. In cultured mouse
GECs, α-actinin-4 was found along actin stress ﬁbers, focal
adhesions, and within the cortical actin network at the cell
periphery (Figure 1)[ 33]. Analogous ﬁndings were evident
in rat GECs [34, 35]. This speciﬁc subcellular localization
of α-actinin-4 facilitates its regulation of adhesion and
cytoskeletal dynamics [19, 33, 36]. Interestingly, α-actinin-
4 was also present in the nucleus of some rat GECs [34,
35], in keeping with earlier reports in other cell lines
[10]. Normally, α-actinin-4 may be required for integrin-
dependent adhesion of GECs [36]. Indeed, knockout of α-
actinin-4 in mice resulted in reduced glomerular podocyte
number, accompanied by the appearance of urinary Wilm’s
tumor-1 (WT-1), a podocyte biomarker. Such podocyte loss
is consistent with defective glomerular basement membrane
adhesion, as TUNEL assays failed to detect any apoptotic
cells in α-actinin-4 null glomeruli. The severity of the
resulting phenotype seen in α-actinin-4 null mice (i.e.,
glomerular disease, renal failure, and early death) indicates
that α-actinin-4-mediated podocyte adhesion is critical
for ﬁltration barrier function [30, 37, 38]. On the other
hand, transgenic podocyte overexpression of wild-type α-
actinin-4 in mice did not alter glomerular ﬁltration barrier
function [39]. These ﬁndings suggest that podocytes tolerate
aw i d er a n g eo fα-actinin-4 expression, but that a minimum
threshold level is essential for normal GEC adhesion to the
glomerularbasementmembranethroughitsinteractionwith
integrins.
3.2. Eﬀects of Mutations in α-Actinin-4 on Podocyte Cytoskele-
tal Structure and Function. Deﬁciency of α-actinin-4 lead-
ing to human disease is not described, but several point
mutations or single amino acid deletions in α-actinin-
4 are found in heritable forms of human FSGS. Most
mutations in ACTN4-associated FSGS families congregate
at the CH1-CH2 interface [9, 40]. An example is the
autosomal dominant K255E mutation (K256E is the mouse
mutant corresponding to human K255E). Such mutants
show increased binding to actin ﬁlaments, compared with
the wild-type protein [30, 41, 42]. Interestingly, α-actinin-
4 K256E is insensitive to regulation by Ca2+ and phos-
phoinositides (PIP2 and PIP3), suggesting that its gain of
aﬃnity for F-actin blunts its responsiveness to regulatory
factors [19]. Expression of an α-actinin-4 K256E transgene
inmousepodocytesinvivo (underthecontrolofthenephrin
promoter)resultedindevelopmentofproteinuricFSGS[41].
In addition, homozygous (but not heterozygous) “knock-
in” of the mutant α-actinin-4 allele into the ACTN4 locus
in mice induced proteinuria [30], conﬁrming the pathogenic
potential of α-actinin-4 mutations.
The underlying biochemical mechanism, whereby FSGS-
associated ACTN4 mutations enhance aﬃnity for actin, was
uncovered by Pollak’s group. They showed that disease-
causing mutations disable an important intramolecular
hinge that normally holds CH1 and CH2 in a “closed”
conformation [43]. The mutant protein adopts an open
conformation forcing an interaction of all three actin-
binding sites with the actin ﬁlament, thereby increasing the
bindingaﬃnitybyloweringitsrateofdissociationfromactin
[44].
4. How Do the Biophysical Effects of Mutant
α-Actinin-4TranslateintoaDysfunctional
Cellular Phenotype?
Although α-actinin-4 is widely expressed, human podocytes
appear to be selectively vulnerable to mutations in α-
actinin-4 (including K256E and other analogous mutants),
perhaps because podocytes are “terminally diﬀerentiated”
cells with limited regenerative capacity. The downstream
cellular mechanism(s) by which mutant α-actinin-4 leads
to podocyte injury and FSGS is poorly understood. One
possibility is that injury is secondary to alterations in
the mechanical properties of the podocyte via increased
aﬃnity of mutant α-actinin-4 for F-actin (Figure 2). GECs
that express α-actinin-4 K256E show defective spreading
and motility (Figure 1)[ 33]. Moreover, exposure of α-
actinin-4 K256E expressing GECs to cyclical equibiaxial
stretch, an in vitro mimic of the mechanical forces due
to glomerular capillary pressure, signiﬁcantly reduced cell
surface area and caused retraction of cellular processes
[19]. Lastly, the enhanced association with F-actin alters
the subcellular localization of α-actinin-4, restricting its
presence at the cell periphery (Figure 1), and potentially
altering its capacity to interact with various binding partners
[19, 33]. Such abnormalities could, at least in part, be
attributable to cytoskeletal disruption, as well as loss of
integrin engagement, eﬀectively yielding a phenotype similar
to that of the α-actinin-4 null mouse [36, 43]. Since the
actin cytoskeleton is a key component contributing to the
unique morphological characteristics of the podocyte foot
processes, as well as being connected to both slit diaphragm
and adhesion complexes, altered α-actinin-4 biology must
have important implications for podocyte health.
An alternate and/or parallel mechanism, which we also
consider in this paper, is that mutant α-actinin-4 induces
proteotoxicity in podocytes (i.e., an impairment of podocyte4 Journal of Signal Transduction
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Figure 1: Subcellular localization of wild-type and K256E α-actinin-4 in mouse podocytes and eﬀects on cell spreading. (a) Diﬀerentiated
podocytes were infected with adenoviruses encoding HA-tagged α-actinin-4 K256E and wild type. Cells were ﬁxed and stained with an anti-
HA antibody to detect α-actinin-4, and phalloidin to detect F-actin. Uninfected cells were treated in the same manner and serve as control.
Wild-type α-actinin-4 is predominantly found with membrane-associated cortical actin and process-like projections with limited expression
along stress ﬁbers. Conversely, α-actinin-4 K256E is predominantly associated with stress ﬁbers and is excluded from the cell periphery. (b)
Ad i ﬀerentiated mouse podocyte expressing GFP-tagged wild-type or K256E α-actinin-4. The wild type expressing cell forms numerous
α-actinin-4-containing lamellipodia in response to serum stimulation. While α-actinin-4 K256E readily decorates actin stress ﬁbers, it,
nevertheless, forms large aggregates, and the cells fail to produce lamellipodia. (c, d) Diﬀerentiated mouse podocytes expressing GFP alone
(control), wild-type, or K256E α-actinin-4 were trypsinized, held in suspension for 15min, replated onto collagen I-coated coverslips, and
analyzed by ﬂuorescence microscopy at 3 and 6h. Expression of α-actinin-4 K256E signiﬁcantly reduced the number of spreading cells. After
6h,wild-typeα-actinin-4waslocalized tocorticalactin,whereasK256E α-actinin-4remainedcondensedwithinthecell.(b)
∗P <. 05versus
control and wild-type of corresponding time point. Panels (a), (c), and (d) of the ﬁgure are adapted from [33] with permission from the
Nature Publishing Group.
function caused by misfolding of a protein), ultimately
leading to apoptosis (Figure 2). Consistent with this notion,
α-actinin-4 K256E forms actin-associated aggregates in
cultured GECs and in podocytes of both homozygous K256E
“knock-in” mice and humans with ACTN4-associated FSGS
[30, 33, 35]. Such misfolded/aggregated protein may be
associatedwiththeactivationofstresspathwaysinpodocytes
(see below).
5. The Ubiquitin-ProteasomeSystemand
Endoplasmic Reticulum(ER)Stress
Prior to discussing the proteotoxic potential of mutant α-
actinin-4, this section provides a brief overview of the
ubiquitin-proteasome system and ER stress. The ubiquitin-
proteasome system plays a key role in regulating the half-life
of short-lived cellular proteins, and in selective degradation
of damaged or abnormal proteins [45, 46]. The protea-
some degrades aberrant cytoplasmic or cytoskeletal proteins,
and misfolded ER proteins, which are retrotranslocated
selectively to the cytoplasm. The latter process is known
as ER-associated degradation (ERAD) [47, 48]. Ubiquitin-
proteasome pathway-mediated protein degradation involves
tagging of the substrate by covalent attachment of ubiquitin
molecules via a three-step reaction, and degradation of the
tagged protein by the 26S proteasome complex. Ubiquiti-
nated proteins typically undergo eﬃcient degradation by the
proteasome,butsometimes,largeamountsofmisfoldedpro-
teins are not degraded eﬀectively, and may form covalently-
linked aggregates. Such misfolded proteins and/or aggregates
may impair the function of the proteasome and lead to the
activation of stress pathways and cytotoxicity [45].
Secretory, luminal, and membrane proteins normally
attain their correctly folded conformation in the ER via
ER-resident chaperones. To rescue misfolded proteins, the
ER has in place quality control machinery, including the
unfolded protein response (UPR) [49–53], and ERAD [47,
48]. In the UPR, accumulation of misfolded proteins in the6 Journal of Signal Transduction
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Figure 2: Podocyte injury induced by mutant α-actinin-4. (a) Potential actions of α-actinin-4 K256E and other FSGS-associated mutants.
(b, c) Potential mechanisms for the cytoskeletal (b) and proteotoxic (c) eﬀects of mutant α-actinin-4 in the podocyte.
ER results in the activation of three ER “sensors”. Activating
transcription factor-6movesfromtheER totheGolgi, where
it is cleaved by proteases. The cleaved cytosolic fragment
translocates to the nucleus to activate transcription of ER
chaperones, for example, the glucose-regulated proteins
(grp), grp94 and bip (grp78), and others. In parallel, inositol
requiring-1α activates its endoribonuclease activity, cleaving
X-box binding protein-1 mRNA and changing the reading
frame to yield a potent transcriptional activator. Normally,
ER chaperones assist in posttranslational processing of
proteins and in their exit from the ER, and may complex
with defective proteins to target them for degradation.
During stress, induction of ER chaperones may enhance the
proteinfoldingcapacity,andlimitaccumulationofabnormal
proteins.
Misfolded proteins in the ER also activate PERK (PKR-
like ER kinase), which then phosphorylates the eukaryotic
translation initiation factor-2α subunit (eIF2α). This process
reduces initiation AUG codon recognition, and the general
rate of translation is blunted (which decreases the protein
load on a damaged ER). The UPR allows cells to recover
from stress, and may be protective to additional insults, but
substantial/prolonged ER stress may lead to apoptosis. For
example, certain mRNAs may be translated preferentially
after eIF2α is phosphorylated. Among these is activating
transcription factor-4, which induces expression of several
genes, including CHOP (C/EBP homologous protein-10;
also known as GADD153), a gene closely associated with
apoptosis and/or growth arrest [49, 51]. Apoptosis may also
result from activation of caspase-12 or protein kinases [49,
51]. Impairment of the ubiquitin-proteasome system can be
associatedwithexacerbationofERstress[49,54],perhapsby
interference with ERAD.
6. Evidence for the Proteotoxicityof
α-Actinin-4K256E
The potential for mutant α-actinin-4 to impair podocyte
function is suggested by the characteristics of this mutant
protein to form microaggregates, undergo ubiquitination,
impair the ubiquitin-proteasome system, enhance ER stress,
and enhance apoptosis (Figure 2).
6.1. α-Actinin-4 K256E Forms Microaggregates. Density-
gradient centrifugation of the K255E mutant α-actinin-4
showed abnormal sedimentation, suggesting that the mutant
protein forms high molecular mass aggregates [30]. In
keeping with this result, expression of α-actinin-4 K255E
(and other FSGS-inducing mutants), but not wild-type α-
actinin-4 in cultured mouse GECs resulted in formation of
aggregates, as visualized by ﬂuorescence microscopy [30, 33,
42, 43]. Analogous results were obtained in rat GECs stably
transfected with α-actinin-4 K256E, where in some cells, the
mutant (but not the wild type) protein formed aggregates
[35]. Unlike the wild-type protein, the mutant was notJournal of Signal Transduction 7
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Figure 3: α-actinin-4 K256E “chokes” the proteasome and exacerbates ER stress. (a) GFP-α-actinin-4 K256E undergoes ubiquitination.
COS-1 cells were transiently transfected with GFP-α-actinin-4 wild type (WT) or K256E mutant (Mut), and the cells were incubated with
the proteasome inhibitor, MG132. Lysates were immunoprecipitated with anti-GFP antibody (+), or nonimmune IgG (−) in controls.
Then, the immunoprecipitates were immunoblotted with antibodies to ubiquitin (upper panel) or GFP (lower panel). (b, c) COS cells
were transiently cotransfected with the GFPU proteasome reporter (or GFP for comparison), plus GFP-α-actinin-4 K256E or wild type.
Lysates were immunoblotted with anti-GFP antibody. In COS cells transfected with α-actinin-4 wild type, expression of the GFPU reporter
is substantially lower than GFP, since GFPU is readily degraded by the ubiquitin-proteasome pathway, but GFP is stable. Mutant α-actinin-4
did not aﬀect GFP expression. GFPU expression was enhanced by cotransfection of α-actinin-4 K256E, indicating that this mutant impaired
degradation of GFPU by the ubiquitin-proteasome system. (c)
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present in the nucleus of rat GECs [34, 35]. In addition, α-
actinin-4 K255E formed aggregates in podocytes of homozy-
gous K255E “knock-in” mice and humans with ACTN4-
associated FSGS [30]. Misfolded/aggregated proteins may
result in the activation of stress pathways [45].
6.2. α-Actinin-4 K256E Undergoes Ubiquitination and Pro-
teasomal Degradation. In pulse-chase metabolic labeling
experiments,mutantα-actinin-4wasdegradedmorerapidly,
compared with the wild-type protein, with the mutant
showing a half-life of ∼15h, and the wild type of over 30h
[30]. Consistent with this result, after stable transfection in
rat GECs or transient transfection in COS cells (a monkey
kidney cell line, which allows for high levels of protein
expression), the level of α-actinin-4 K256E protein was
considerably lower, compared with the wild-type protein
(Figure 3)[ 34, 35]. Together, these results suggested that
α-actinin-4 K256E may undergo ubiquitination prior to
degradation via the ubiquitin-proteasome pathway. Indeed,
in transiently transfected COS cells, mutant α-actinin-4 was
polyubiquitinated, whereas the wild-type protein was not
(Figure 3)[ 35]. Treatment of GECs that express α-actinin-
4 K256E with proteasome inhibitors enhanced expression
of α-actinin-4 K256E, in keeping with ubiquitination and
degradation of the mutant protein by the proteasome [30,
35].
6.3. α-Actinin-4 K256E Impairs the Ubiquitin-Proteasome
Pathway. α-actinin-4 K256E and wild-type proteins were
transiently overexpressed in COS cells to study their eﬀects
on the ubiquitin-proteasome system. The function of the
ubiquitin-proteasome system was monitored in viable cells
by use of a reporter consisting of a short degron, CL1,
fused to the C-terminus of green ﬂuorescent protein
(GFPU)[ 55]. This GFPU proteasome reporter is rapidly
degraded when ubiquitin-proteasome function is normal,
whereas impairment of the ubiquitin-proteasome system,
for example, via enhanced ﬂux of a mutant/aggregated
p r o t e i nw i l lr e d u c ed e g r a d a t i o no fG F P U, resulting in an
increased level of GFPU expression. In COS cells transfected
with wild-type α-actinin-4, expression of GFPU declined
signiﬁcantly, in keeping with proteasomal degradation of
GFPU (Figure 3). In contrast, expression of α-actinin-4
K256E retarded the degradation of GFPU, implying that the
ubiquitin-proteasome system was impaired in the presence
of mutant α-actinin-4 [35].
6.4. α-Actinin-4 K256E Enhances ER Stress. α-actinin-4 is
a cytosolic/cytoskeletal protein that normally would not
enter the ER to undergo posttranslational modiﬁcation.
Nonetheless, compared with α-actinin-4 wild type, transient
transfection of α-actinin-4 K256E in COS cells enhanced
the UPR, as evidenced by increased expression of the
ER chaperone, grp94, and the proapoptotic gene, CHOP
(Figure 3)[ 35]. In GECs, expression of the K256E mutant or
wildtypeα-actinin-4(bystabletransfection)didnotincrease
expression of the ER chaperone, bip, or CHOP, compared
with parental (untransfected) cells. This diﬀerence between
COS cells and GECs may be due to lower expression of stably
transfected proteins in the GECs. However, after incubation
of GECs with tunicamycin (a drug that blocks N-linked
glycosylation and causes an accumulation of misfolded
proteins in the ER [51]), the GECs stably transfected with
α-actinin-4 K256E showed increases in bip and CHOP that
signiﬁcantly exceeded the increases seen in cells expressing
the wild-type protein, as well as the increases in parental
GECs [35]. The eﬀect of α-actinin-4 K256E on the induction
of the UPR by tunicamycin was particularly robust, given
that expression of the mutant was substantially lower than
the wild-type protein. Thus, although stable expression of α-
actinin-4 K256E in GECs did not induce the UPR directly,
the mutant appeared to adversely aﬀect the integrity of
the ER, which may render these cells more susceptible
to additional stress and induction of proapoptotic genes.
Together, these results are in keeping with the view that
exacerbation of ER stress may be secondary to impairment
of the ubiquitin-proteasome system [49, 54].
6.5. Mutant α-Actinin-4 Aﬀects Apoptosis/Cell Survival. Sta-
ble expression of α-actinin-4 K256E in GECs led to a
reduction in cell number, as well as increased apoptosis
and caspase-3 activity, compared with GECs that stably
express α-actinin-4 wild type, or parental (untransfected)
GECs [34]. These changes in cell number and apoptosis
in the presence of α-actinin-4 K256E occurred despite the
signiﬁcantly lower expression level of the mutant, compared
with the wild-type α-actinin-4, highlighting the potential
detrimental consequences of this mutation. In COS cells, α-
actinin-4 K256E had only a slight eﬀect on apoptosis and cell
number, suggesting that this cell type may be more resistant
to cytotoxicity. Nevertheless, α-actinin-4 K256E markedly
exacerbated apoptosis and reduced cell number in the con-
text of mild proteasome inhibition [35]. This result supports
the view that apoptosis induced by mutant α-actinin-4 may
be associated with an impairment in proteasome function.
6.6. ER Stress Is Evident in α-Actinin-4 K256E-Associated
Podocyte Injury. The eﬀects of α-actinin-4 K256E on the
UPR (discussed above) are based on studies in cultured cell
lines, but importantly, analogous changes also occurred in
vivo. As stated above, transgenic mice that express an α-
actinin-4 K256E transgene in podocytes develop proteinuria
and FSGS [41]. Glomeruli were isolated from these mice
and examined for evidence of ER stress [35]. Expression of
the ER chaperones, bip and grp94, eIF2α phosphorylation,
as well as expression of the proapoptotic protein, CHOP,
were increased in glomeruli of transgenic mice, compared
with control. Based on these results, it is reasonable to
propose that in the α-actinin-4 K256E model of FSGS, there
is pronounced ER stress, which may be contributing, at least
in part, to GEC apoptosis.
7. Conclusion
The maintenance of a highly dynamic actin-based cytoskele-
ton is critically important to podocyte morphology andJournal of Signal Transduction 9
function. Microﬁlaments in the foot processes tether the
actin cytoskeleton to the slit diaphragm and adhesion
complexes, while forming the architectural infrastructure for
the foot processes. α-actinin-4 provides structural support to
thesemicroﬁlamentsviaits crosslinking andbundling activi-
ties, while linking them to components of the slit diaphragm
and sites of adhesion. The gain aﬃnity mutations in FSGS-
associatedα-actinin-4substantiallyalterthepropertiesofthe
actin cytoskeleton, rendering it more rigid and less dynamic.
Therefore,theunderlyingpathogenesisofACTN4-associated
podocyte injury, glomerular ﬁltration barrier dysfunction
and the appearance of FSGS lesions are at least partly
attributable to an aberrantly high interaction of α-actinin-4
with F-actin and its impact upon the cytoskeleton.
In addition, the enhanced actin-α-actinin-4 interaction
generates misfolded protein/aggregates, which could provide
a parallel mechanism of podocyte dysfunction. As discussed
above, misfolded proteins may induce dysfunction of the
ubiquitin-proteasome system, that is, the misfolded proteins
“choke” or “gum up” the proteasome, and this process
may enhance proapoptotic stress in cellular compartments,
including the ER. In addition, since ubiquitination regu-
lates many essential cellular processes, including normal
protein degradation, cell cycle, transcription, DNA repair,
and protein traﬃcking, a disrupted ubiquitin-proteasome
system may have broader adverse consequences for cell
function [46]. Thus, the pathogenesis of FSGS associated
with α-actinin-4 K256E may resemble processes in certain
age-related or neurodegenerative diseases, where signs of
ER stress, UPS dysfunction, and protein misfolding are
observed [30, 45, 54, 56–58]. For example, in Huntington’s
disease, the expansion of a glutamine stretch within the
N-terminal region of huntingtin gene generates a protein
with severe neurotoxic properties. Expression of mutant
huntingtin leads to a pronounced defect in ERAD, and
UPR activation was noted in postmortem Huntington’s
disease brains. Familial amyotrophic lateral sclerosis has
been linked to mutations in the gene encoding superoxide
dismutase-1, and these mutations induce misfolding and
aggregation of this protein, which is believed to contribute
to neuronal dysfunction and death. Activation of the UPR
is observed in mutant superoxide dismutase-1 transgenic
mice, and increased levels of ER stress markers, as well
as wild-type superoxide dismutase-1 aggregates have been
reported in spinal cord tissue of sporadic amyotrophic lateral
sclerosis. Modulation of ER stress pathways protected mice
with experimental amyotrophic lateral sclerosis from disease
progression. Other examples of neurodegenerative diseases
associated with protein misfolding/aggregation and ER stress
are Alzheimer’s, Parkinson’s, and prion diseases. Protein
misfolding and UPS dysfunction also appears to play a
role in desmin-related cardiomyopathies, which result in
congestive heart failure [46]. By analogy to experimental
neurodegenerative disease models, one must, however, be
cautious in extrapolating the cell culture events, which are
based on overexpression and a relatively brief experimental
time frame, to a disease process that in humans takes many
years to become established. Finally, the shuttling of the wild
type, but not mutant α-actinin-4 between the cytoplasm
and the nucleus, as well as the potential for disruption of
gene regulation in the presence of mutant α-actinin-4, will
require additional consideration as a potential mechanism
of podocyte injury in FSGS. These various mechanistic
relationships between abnormal proteins and cell injury will
require further study.
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